News
If you’re pregnant or hoping to become pregnant, it’s natural to have questions about your medications. And if you’re taking ...
THE price of Mounjaro is set to soar, The Sun revealed yesterday – leaving slimmers desperate and worried at how they will ...
Mounjaro, one of the UK’s most popular weight-loss jabs, is set to become more expensive for private patients after Eli Lilly ...
Glucagon-like peptide 1 receptor agonists, including semaglutide, have increased in use and will continue to increase due to their effectiveness in weight loss.
People taking weight loss drugs typically start to lose weight within a few weeks. One study, funded by Mounjaro manufacturer ...
Novo Nordisk’s challenges from both a pharmaceutical giant in Lilly and the low-cost competition from compounded drugs sellers led to its leadership change. Novo Nordisk announced in May that Lars ...
Digestion issues, fatigue, and high costs haven’t stopped some from finding power and transformation through GLP-1 ...
Once the golden child of the weight-loss boom, the Danish drugmaker now faces a painful financial slimming of its own.
Semaglutide is the active ingredient in the weight loss medication Wegovy and the diabetes drugs Ozempic and Rybelsus, which ...
Vivani Medical Inc. (NASDAQ:VANI) on Tuesday reported results from the LIBERATE-1 Phase 1 study of the exenatide GLP-1 implant NPM-115, representing the first-in-human test of the company's ...
4d
Pharmaceutical Technology on MSNWeightWatchers shuns compounded semaglutide amid FDA rules
WeightWatchers is now only offering Wegovy while other telehealth providers defiantly hang on to compounded alternatives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results